Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (301-310 of 330) with videos related to

Pageof 33
Sort By:
The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Clinical Breast Cancer|September 28, 2019
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022Rachel A Freedman, Rebecca S Gelman, Nathalie Y R Agar, et al.
Nature Medicine|June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial resultsPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Pageof 33

Showing results (301-310 of 330) with videos related to

Sort By:
Pageof 33
The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Clinical Breast Cancer|September 28, 2019
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022Rachel A Freedman, Rebecca S Gelman, Nathalie Y R Agar, et al.
Nature Medicine|June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial resultsPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Pageof 33